A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
Titel:
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
Auteur:
Lacouture, M.E. Keefe, D.M. Sonis, S. Jatoi, A. Gernhardt, D. Wang, T. Doherty, J.P. Giri, N. Nadanaciva, S. O'Connell, J. Sbar, E. Piperdi, B. Garon, E.B.